{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:25:10Z","timestamp":1766157910230},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/md.0000000000002104","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T18:31:50Z","timestamp":1449081110000},"page":"e2104","source":"Crossref","is-referenced-by-count":29,"title":["A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection"],"prefix":"10.1097","volume":"94","author":[{"given":"Ping-I","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Shuo","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng-Chyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Chung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huay-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Hung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shiung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng-Kee","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Woei","family":"Tsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","article-title":"Antibacterial treatment of gastric ulcer associated with Helicobacter pylori","volume":"332","author":"Sung","year":"1995","journal-title":"N Engl J Med"},{"key":"R2-8-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1440-1746.1998.tb00540.x","article-title":"Helicobacter pylori: from art to a science","volume":"13","author":"Hunt","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"R3-8-20210309","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-8-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199600001-00002","article-title":"Recent developments in our understanding of gastric lymphomas","volume":"20","author":"Isaacson","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R5-8-20210309","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"R6-8-20210309","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection","volume":"24","author":"Fock","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-8-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2009.00738.x","article-title":"Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition","volume":"15","author":"Asaka","year":"2010","journal-title":"Helicobacter"},{"key":"R8-8-20210309","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"R9-8-20210309","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R10-8-20210309","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ncpgasthep1138","article-title":"New concepts of resistance in the treatment of Helicobacter pylori infections","volume":"5","author":"Graham","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R11-8-20210309","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H. pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"Megraud","year":"2004","journal-title":"Gut"},{"key":"R12-8-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"Luther","year":"2010","journal-title":"Am J Gastroenterl"},{"key":"R13-8-20210309","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3748\/wjg.v10.i5.668","article-title":"Low eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey","volume":"10","author":"Gumurdulu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R14-8-20210309","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2036.1998.00315.x","article-title":"One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin","volume":"12","author":"Bigard","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-8-20210309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jac\/dkm005","article-title":"Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15-year period in Italy","volume":"59","author":"De Francesco","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R16-8-20210309","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"R17-8-20210309","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1128\/AAC.02922-14","article-title":"Comparison of 7-day triple, 10-day sequential and 7-day concomitant therapies for Helicobacter pylori infection\u2014a randomized controlled trial","volume":"214","author":"Hsu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-8-20210309","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2036.2011.04770.x","article-title":"Non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori","volume":"34","author":"Gisbert","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-8-20210309","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X10384171","article-title":"Should quinolones come first in Helicobacter pylori therapy?","volume":"4","author":"Berning","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"R20-8-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1523-5378.2011.00828.x","article-title":"Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days","volume":"16","author":"Hsu","year":"2011","journal-title":"Helicobacter"},{"key":"R21-8-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/hel.12017","article-title":"Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial","volume":"18","author":"Sardarian","year":"2013","journal-title":"Helicobacter"},{"key":"R22-8-20210309","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1099\/jmm.0.072322-0","article-title":"Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study","volume":"63","author":"De Francesco","year":"2014","journal-title":"J Med Microbiol"},{"key":"R23-8-20210309","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jgh.12518","article-title":"The efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy","volume":"29","author":"Oh","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R24-8-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"},{"key":"R25-8-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2010.210","article-title":"Optimal therapy for Helicobacter pylori infections","volume":"8","author":"Rimbara","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R26-8-20210309","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v17.i35.3971","article-title":"A new look at anti-Helicobacter pylori therapy","volume":"17","author":"Chuah","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R28-8-20210309","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/hel.12113","article-title":"Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate","volume":"19","author":"Wu","year":"2014","journal-title":"Helicobacter"},{"key":"R29-8-20210309","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hel.12176","article-title":"Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial","volume":"20","author":"Tsay","year":"2015","journal-title":"Helicobacter"},{"key":"R30-8-20210309","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2010.11.056","article-title":"Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis","volume":"140","author":"Hsu","year":"2011","journal-title":"Gastroenterology"},{"key":"R31-8-20210309","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MD.0b013e31821c9d1c","article-title":"Helicobacter pylori Infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies","volume":"90","author":"Wu","year":"2011","journal-title":"Medicine"},{"key":"R32-8-20210309","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1523-5378.2011.00829.x","article-title":"Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?","volume":"16","author":"Hsu","year":"2011","journal-title":"Helicobacter"},{"key":"R33-8-20210309","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1111\/j.1572-0241.2005.00264.x","article-title":"A prospective randomized trial of esomeprazole-versus pantoprazole based triple therapy for Helicobacter pylori eradication","volume":"100","author":"Hsu","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R34-8-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2009.09.030","article-title":"Sequential and concomitant therapy with 4 drugs are equally effective for eradication of H. pylori infection","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-8-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R37-8-20210309","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2012","journal-title":"Lancet"},{"key":"R38-8-20210309","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2133\/dmpk.20.153","article-title":"Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies","volume":"20","author":"Furuta","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"R39-8-20210309","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkp034","article-title":"Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial","volume":"63","author":"Kuo","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:54:45Z","timestamp":1620960885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201512010-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002104","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}